Department of Medicinal Chemistry, University of Michigan, Ann Arbor, Michigan 48109-1065, United States.
Department of Pharmacology, University of Michigan, Ann Arbor, Michigan 48109-5632, United States.
J Chem Inf Model. 2022 Feb 14;62(3):618-626. doi: 10.1021/acs.jcim.1c01223. Epub 2022 Feb 2.
In this study, we target the main protease (M) of the SARS-CoV-2 virus as it is a crucial enzyme for viral replication. Herein, we report three plausible allosteric sites on M that can expand structure-based drug discovery efforts for new M inhibitors. To find these sites, we used mixed-solvent molecular dynamics (MixMD) simulations, an efficient computational protocol that finds binding hotspots through mapping the surface of unbound proteins with 5% cosolvents in water. We have used normal mode analysis to support our claim of allosteric control for these sites. Further, we have performed virtual screening against the sites with 361 hits from M screenings available through the National Center for Advancing Translational Sciences (NCATS). We have identified the NCATS inhibitors that bind to the remote sites better than the active site of M, and we propose these molecules may be allosteric regulators of the system. After identifying our sites, new X-ray crystal structures were released that show fragment molecules in the sites we found, supporting the notion that these sites are accurate and druggable.
在这项研究中,我们以 SARS-CoV-2 病毒的主要蛋白酶(M)为目标,因为它是病毒复制的关键酶。在此,我们报告了 M 上三个可能的别构位点,这可以扩展基于结构的药物发现工作,以寻找新的 M 抑制剂。为了找到这些位点,我们使用了混合溶剂分子动力学(MixMD)模拟,这是一种有效的计算方案,通过在水中用 5%的共溶剂映射未结合蛋白的表面来找到结合热点。我们使用正常模式分析来支持我们对这些位点的变构控制的主张。此外,我们还针对这些位点进行了虚拟筛选,使用了来自国家转化医学推进中心(NCATS)的 M 筛选中可用的 361 个命中。我们已经确定了 NCATS 抑制剂,它们与 M 的活性位点相比,与远程位点的结合更好,我们提出这些分子可能是该系统的变构调节剂。在确定了我们的位点后,新的 X 射线晶体结构的发布表明,在我们发现的位点存在片段分子,这支持了这些位点是准确的和可成药的观点。